The pharmaceutical landscape is constantly shifting, with mergers and acquisitions driving significant changes. In this dynamic environment, Wockhardt has emerged as a potential target for various players in the market. Several factors contribute to this interest, including its strong portfolio of generic drugs and its significant global reach.